Skip to content

Enovis ENOV Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)

Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) at other companies

Baxter International logo
Baxter InternationalBAX

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's total cash, cash equivalents, and restricted cash (inclusive).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's total cash, cash equivalents, and restricted cash (inclusive)?
Enovis (ENOV) reported total cash, cash equivalents, and restricted cash (inclusive) of $33.13M in Q1 2026.
How has Enovis's total cash, cash equivalents, and restricted cash (inclusive) changed year-over-year?
Enovis's total cash, cash equivalents, and restricted cash (inclusive) decreased by 13.9% year-over-year, from $38.46M to $33.13M.
What is the long-term trend for Enovis's total cash, cash equivalents, and restricted cash (inclusive)?
Over 5 years (2020 to 2025), Enovis's total cash, cash equivalents, and restricted cash (inclusive) has grown at a -18.5% compound annual growth rate (CAGR), from $101.07M to $36.39M.